Scope Fluidics Spolka Akcyjna (FRA:S84) Enterprise Value: €58.14 Mil (As of Jul. 02, 2026) ***


FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
45 GF Score
Price €24.20
GF Value €26.71
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Enterprise Value?

Scope Fluidics Spolka Akcyjna FRA:S84 +2.98% 45 Enterprise Value is €58.14 Mil as of Jul. 02, 2026. GuruFocus rates FRA:S84 with a GF Score™ of 45/100 and a GF Value™ of €26.71. The stock has 4 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Scope Fluidics Spolka Akcyjna's Enterprise Value is €58.14 Mil. Scope Fluidics Spolka Akcyjna's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €-10.62 Mil. Therefore, Scope Fluidics Spolka Akcyjna's EV-to-EBIT ratio for today is -5.48.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Scope Fluidics Spolka Akcyjna's Enterprise Value is €58.14 Mil. Scope Fluidics Spolka Akcyjna's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €-10.10 Mil. Therefore, Scope Fluidics Spolka Akcyjna's EV-to-EBITDA ratio for today is -5.76.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Scope Fluidics Spolka Akcyjna's Enterprise Value is €58.14 Mil. Scope Fluidics Spolka Akcyjna's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €0.02 Mil. Therefore, Scope Fluidics Spolka Akcyjna's EV-to-Revenue ratio for today is 2,527.78.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Scope Fluidics Spolka Akcyjna's Enterprise Value is €58.14 Mil. Scope Fluidics Spolka Akcyjna's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was €-11.67 Mil. Therefore, Scope Fluidics Spolka Akcyjna's EV-to-OCF ratio for today is -4.98.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Scope Fluidics Spolka Akcyjna's Enterprise Value is €58.14 Mil. Scope Fluidics Spolka Akcyjna's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €-14.89 Mil. Therefore, Scope Fluidics Spolka Akcyjna's EV-to-FCF ratio for today is -3.91.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Scope Fluidics Spolka Akcyjna  (FRA:S84) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Scope Fluidics Spolka Akcyjna's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=58.139/-10.615
=-5.48

Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil.
Scope Fluidics Spolka Akcyjna's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-10.62 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Scope Fluidics Spolka Akcyjna's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=58.139/-10.096
=-5.76

Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil.
Scope Fluidics Spolka Akcyjna's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-10.10 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Scope Fluidics Spolka Akcyjna's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=58.139/0.023
=2,527.78

Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil.
Scope Fluidics Spolka Akcyjna's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Scope Fluidics Spolka Akcyjna's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=58.139/-11.674
=-4.98

Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil.
Scope Fluidics Spolka Akcyjna's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.67 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Scope Fluidics Spolka Akcyjna's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=58.139/-14.888
=-3.91

Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil.
Scope Fluidics Spolka Akcyjna's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scope Fluidics Spolka Akcyjna Enterprise Value Related Terms


Scope Fluidics Spolka Akcyjna Enterprise Value Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Enterprise Value Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.11 36.23 93.88 82.31 83.51

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.67 54.90 67.69 83.51 59.43

FRA:S84 vs TMO, DHR, IDXX: Enterprise Value Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Enterprise Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Enterprise Value falls into.


FRA:S84
45GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Scope Fluidics Spolka Akcyjna's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Scope Fluidics Spolka Akcyjna's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of €58.14 Mil mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a Enterprise Value of €58.14 Mil as of Jul. 02, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Enterprise Value too high?
Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Enterprise Value compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Enterprise Value of €58.14 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Enterprise Value is €58.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current Enterprise Value of €58.14 Mil. The stock's GF Value™ is €26.71, compared to a current price of €24.20 — trading 9.4% below its estimated fair value. The current Enterprise Value is €58.14 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current Enterprise Value is €58.14 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of €24.20 is trading 9.4% below its estimated GF Value™ of €26.71.

Key valuation signals for FRA:S84:

  • Enterprise Value: €58.14 Mil
  • GF Value™: €26.71 vs. price of €24.20 (9.4% below fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
45GF Score

Get the complete analysis for FRA:S84

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€24.20
Price
€26.71
GF Value